Sökresultat

Filtyp

Din sökning på "what do you do on the dark web 【Visit Sig8.com】9ZP42K8.5R9I" gav 103537 sökträffar

New type of blood test gives more reliable diagnosis of Alzheimer’s disease

A simple blood test with 90% accuracy that shows whether a patient has Alzheimer’s disease has floored the research community, which is calling it a gamechanger. Oskar Hansson, professor of neurology at Lund University and Skåne University Hospital, is leading the research team that has rapidly taken a major step towards better diagnostics. “The blood test will make it easier for general practitio

https://www.lunduniversity.lu.se/article/new-type-blood-test-gives-more-reliable-diagnosis-alzheimers-disease - 2026-07-19

Universal method could transform the future of bone transplantation

Bone and skeletal injuries cause extensive and long-term functional impairments worldwide. In a new study, researchers at Lund University in Sweden show how a cell-free cartilage structure can safely guide bone repair without triggering strong immune responses. The transplant has been successfully tested in animal models, and the next step is to evaluate the tissue engineering approach in humans.

https://www.stemcellcenter.lu.se/article/universal-method-could-transform-future-bone-transplantation - 2026-07-19

Hindrik Mulder is the incoming editor-in-chief of Diabetologia

This article is over 5 years old, and the information may therefore be outdated. Research published in the research journal Diabetologia needs to meet a high standard of quality. Most of the manuscripts submitted are rejected. At the start of 2021, Hindrik Mulder, MD and professor at Lund University Diabetes Centre (LUDC), will take over as editor-in-chief of the journal. After just over 10 years

https://www.medicine.lu.se/article/hindrik-mulder-incoming-editor-chief-diabetologia - 2026-07-19

Daniella Rylander Ottosson named as Wallenberg Academy Fellow

Using methods for reprogramming human glia cells top create specialised nerve cells, interneurons, researcher Daniella Rylander Ottosson aims to lay the foundations for future treatments of diseases such as schizophrenia and epilepsy. Of the 27 new Wallenberg Academy Fellows, two are at Lund University: Daniella Rylander Ottosson, who is conducting research into regenerative neurophysiology at the

https://www.medicine.lu.se/article/daniella-rylander-ottosson-named-wallenberg-academy-fellow - 2026-07-19

Largest ever TauPET study of Alzheimer’s deepens understanding of the disease

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.lunduniversity.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-07-19

Psychedelics in the treatment of anorexia – a new pilot study

Anorexia nervosa is a serious psychiatric disorder for which there are limited treatment options, and it has one of the highest mortality rates of any psychiatric diagnosis. A pilot study is now underway at Lund University in Sweden, where researchers are investigating whether psychedelic drugs have an effect on young patients with the disorder. Ward Five at the adult psychiatric clinic in Lund is

https://www.lunduniversity.lu.se/article/psychedelics-treatment-anorexia-new-pilot-study - 2026-07-19

Update on STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing.
STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.lunduniversity.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-07-19

New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.lunduniversity.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-07-19

Update STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.multipark.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-07-19

Alzheimer’s awareness: Five research projects shaping the future of understanding, diagnosis and care

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2026-07-19

Largest ever TauPET study of Alzheimer’s deepens understanding of the disease

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-07-19

New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.multipark.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-07-19

New innovation district to increase the region's innovative capacity

On May 29th, the Helsingborg Innovation District, a collaboration platform and catalyst for innovation, research, and development, will be inaugurated. The innovation district is initiated by the City of Helsingborg, Lund University, Region Skåne, and the Chamber of Commerce and Industry of Southern Sweden in collaboration with the business community. The district stretches from Helsingborg Centra

https://www.ch.lu.se/en/article/new-innovation-district-increase-regions-innovative-capacity - 2026-07-19

How B cells are programmed early in life can impact long-term immune health

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill. Uncovering how they form and are ‘programmed’ during development is key to better understanding the immune response to infections and vaccinations. A new study by researchers from Lund University in Sweden provides new insights into the origin and develo

https://www.medicine.lu.se/article/how-b-cells-are-programmed-early-life-can-impact-long-term-immune-health - 2026-07-19

The four lifestyle choices that most reduce your carbon footprint

This article is over 5 years old, and the information may therefore be outdated. A new study has identified the four actions that would have the greatest impact on an individual’s greenhouse gas emissions: eating a plant-based diet, avoiding air travel, living car free, and having fewer children. The comprehensive study analysed 39 peer-reviewed articles, carbon calculators and government sources

https://www.lunduniversity.lu.se/article/four-lifestyle-choices-most-reduce-your-carbon-footprint - 2026-07-19

Amniotic fluid is a rich source of stem cells – that can now be harvested

Amniotic fluid, the protective liquid surrounding an unborn baby, is discarded as medical waste during caesarean section deliveries. However, there is increasing evidence that this fluid is a source of valuable biological material, including stem cells with the potential for use in cell therapy and regenerative medicine. A team of scientists and clinicians at Lund University in Sweden have now dev

https://www.lunduniversity.lu.se/article/amniotic-fluid-rich-source-stem-cells-can-now-be-harvested - 2026-07-19

Dedicated alumna launched Minnesota model in Sweden

This article is over 5 years old, and the information may therefore be outdated. “Education and knowledge are the way to change society for the better. I want to make a difference and help to give young people the same fantastic opportunities I had”, says alumna Monica Getz Silfverschöld, a new board member for the Lund University Foundation (LUF). LUF is an independent foundation that aims to str

https://www.staff.lu.se/article/dedicated-alumna-launched-minnesota-model-sweden - 2026-07-19

Update STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.medicine.lu.se/article/update-on-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-07-19